Abdul Hamid Bazarbachi

Also affiliated with NewYork–Presbyterian Hospital, Inserm, Columbia University Irving Medical Center, New York Hospital Queens, Sorbonne Université, Columbia University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma”.

Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma

Nature Communications(2021)10.1038/s41467-021-21177-5

N/A

0DataRank · unranked

414 citations

Mariateresa Fulciniti, Anıl Aktaş Samur, Abdul Hamid Bazarbachi, Yu‐Tzu Tai, Rao Prabhala +10 more

IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM

Blood(2021)10.1182/blood.2021011452

N/A

0DataRank · unranked

21 citations

Hervé Avet‐Loiseau, Raphaël Szalat, Anıl Aktaş Samur, Zachary R. Hunter, Masood A. Shammas +9 more

High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma

Blood(2023)10.1182/blood.2022017094

N/A

0DataRank · unranked

48 citations

Marco Roncador, Anıl Aktaş Samur, Mariateresa Fulciniti, Abdul Hamid Bazarbachi, Raphaël Szalat +14 more